The Effect of Mirabegron on Brown Adipose Tissue in Healthy Young White Caucasian and South Asian Men

Trial Profile

The Effect of Mirabegron on Brown Adipose Tissue in Healthy Young White Caucasian and South Asian Men

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Dyslipidaemias; Obesity
  • Focus Therapeutic Use
  • Acronyms MiraBAT
  • Most Recent Events

    • 02 Dec 2017 Status changed from recruiting to completed.
    • 28 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top